Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer

다국어 초록 (Multilingual Abstract)

Objective: To examine the surgical-pathological predictors of para-aortic lymph node (PAN) metastasis at radical hysterectomy, and for PAN recurrence among women who did not undergo PAN dissection at radical hysterectomy.
Methods: This is a retrospective analysis of a nation-wide cohort study of surgically-treated stage IB–IIB cervical cancer (n=5,620). Multivariate models were used to identify independent surgical-pathological predictors for PAN metastasis/recurrence.
Results: There were 120 (2.1%) cases of PAN metastasis at surgery with parametrial involvement (adjusted odds ratio [aOR]=1.65), deep stromal invasion (aOR=2.61), ovarian metastasis (aOR=3.10), and pelvic nodal metastasis (single-node aOR=5.39 and multiple-node aOR=33.5, respectively) being independent risk factors (all, p<0.05). Without any risk factors, the incidence of PAN metastasis was 0.9%, while women exhibiting certain risk factor patterns (>20% of the study population) had PAN metastasis incidences of ≥4%. Among 4,663 clinically PAN-negative cases at surgery, PAN recurrence was seen in 195 (4.2%) cases that was significantly higher than histologically PAN-negative cases (2.5%, p=0.046). In clinically PAN-negative cases, parametrial involvement (adjusted hazard ratio [aHR]=1.67), lympho-vascular space invasion (aHR=1.95), ovarian metastasis (aHR=2.60), and pelvic lymph node metastasis (single-node aHR=2.49 and multiple-node aHR=8.11, respectively) were independently associated with increased risk of PAN recurrence (all, p<0.05). Without any risk factors, 5-year PAN recurrence risk was 0.8%; however, women demonstrating certain risk factor patterns (>15% of the clinically PAN-negative population) had 5-year PAN recurrence risks being ≥8%.
Conclusion: Surgical-pathological risk factors proposed in this study will be useful to identify women with increased risk of PAN metastasis/recurrence.

참고문헌 (Reference)

1 김민정, "Uterine corpus involvement as well as histologic type is an independent predictor of ovarian metastasis in uterine cervical cancer" 대한부인종양학회 19 (19): 181-184, 2008

2 Mikami M, "Surgical principles for managing stage IB2, IIA2, and IIB uterine cervical cancer (bulky tumors) in Japan: a survey of the Japanese Gynecologic Oncology Group" 24 : 1333-1340, 2014

3 von Elm E, "Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies" 335 : 806-808, 2007

4 Matsuo K, "Significance of uterine corpus tumor invasion in early-stage cervical cancer" 43 : 725-734, 2017

5 Koji Matsuo, "Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB–IIB cervical cancer" 대한부인종양학회 29 (29): 1-6, 2018

6 Shimada M, "Ovarian metastasis in carcinoma of the uterine cervix" 101 : 234-237, 2006

7 Koji Matsuo, "Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan" 대한부인종양학회 28 (28): 1-5, 2017

8 National Comprehensive Cancer Network, "NCCN Clinical Practice Guidelines in Oncology. Cervical cancer, version 1.2017" National Comprehensive Cancer Network

9 Benedetti-Panici P, "Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy" 62 : 19-24, 1996

10 Gil-Moreno A, "Location of aortic node metastases in locally advanced cervical cancer" 125 : 312-314, 2012

11 Ebina Y, "Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer" 20 : 240-248, 2015

12 Morice P, "Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma" 73 : 106-110, 1999

13 Tabata M, "Incidence of ovarian metastasis in patients with cancer of the uterine cervix" 28 : 255-261, 1987

14 Sakuragi N, "Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy" 85 : 1547-1554, 1999

15 Matsuo K, "Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer" 2017

16 Torre LA, "Global cancer statistics, 2012" 65 : 87-108, 2015

17 Niibe Y, "Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study" 103 : 435-438, 2006

18 Matsuo K, "Effectiveness of adjuvant systemic chemotherapy for stage IB cervical cancer with intermediate-risk group" 2017

19 Matsuo K, "Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: systemic chemotherapy versus pelvic irradiation" 141 : 1042-1051, 2017

20 Kim PY, "Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging" 69 : 243-247, 1998

21 Saito T, "Annual report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: patient annual report for 2013 and treatment annual report for 2008" 42 : 1069-1079, 2016

22 Gien LT, "Adenocarcinoma: a unique cervical cancer" 116 : 140-146, 2010